Improve Medical Instruments Co., Ltd. (SHE:300030)
China
· Delayed Price · Currency is CNY 8.17
+0.17 (2.13%)
Apr 29, 2026, 3:04 PM CST
SHE:300030 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 28.4 | 14.53 | -117.9 | -63.2 | -198.3 | 18.57 | Upgrade
|
| Depreciation & Amortization | 33.96 | 33.96 | 39.85 | 45.13 | 46.75 | 53.31 | Upgrade
|
| Other Amortization | 1.98 | 1.98 | 2.03 | 3.58 | 2.67 | 2.63 | Upgrade
|
| Loss (Gain) From Sale of Assets | -2.09 | -2.09 | -0.9 | -6.45 | -0.44 | -0.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | 22.6 | 22.6 | 23.33 | 8.99 | 90.08 | 1.39 | Upgrade
|
| Loss (Gain) From Sale of Investments | -10.31 | -10.31 | 63.56 | -7.44 | 53.1 | -19.34 | Upgrade
|
| Provision & Write-off of Bad Debts | -5.28 | -5.28 | 23.96 | -3.08 | 9.1 | 7.75 | Upgrade
|
| Other Operating Activities | 18.46 | 17.25 | 34.52 | 47.92 | 53.47 | 44.18 | Upgrade
|
| Change in Accounts Receivable | 141.92 | 141.92 | 19.6 | 52.76 | -12.59 | 109.82 | Upgrade
|
| Change in Inventory | 9.12 | 9.12 | -0.09 | -19.77 | -16.14 | -15.78 | Upgrade
|
| Change in Accounts Payable | -117.32 | -117.32 | -1.92 | 6.97 | 38.21 | -32.99 | Upgrade
|
| Operating Cash Flow | 124.97 | 109.9 | 81.84 | 79.9 | 42.48 | 171.74 | Upgrade
|
| Operating Cash Flow Growth | 57.33% | 34.29% | 2.42% | 88.11% | -75.27% | 21.56% | Upgrade
|
| Capital Expenditures | -25.21 | -24.12 | -51.28 | -43.7 | -58.04 | -71.05 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.23 | 1.58 | 37.51 | 3.6 | 0.06 | 0.13 | Upgrade
|
| Divestitures | - | - | - | - | 26.6 | 2.71 | Upgrade
|
| Investment in Securities | 1 | 1 | 28.35 | -20 | -13.25 | 5.79 | Upgrade
|
| Other Investing Activities | 8.91 | 26.52 | -1.08 | 21.59 | - | 22.62 | Upgrade
|
| Investing Cash Flow | -14.08 | 4.98 | 13.5 | -38.5 | -44.64 | -39.81 | Upgrade
|
| Long-Term Debt Issued | - | 231.4 | 354.73 | 393.58 | 381.99 | 272.62 | Upgrade
|
| Long-Term Debt Repaid | - | -425.99 | -405.57 | -425.18 | -467.2 | -250.39 | Upgrade
|
| Net Debt Issued (Repaid) | -114.68 | -194.59 | -50.84 | -31.6 | -85.21 | 22.24 | Upgrade
|
| Issuance of Common Stock | - | - | 0.03 | - | - | 9.91 | Upgrade
|
| Common Dividends Paid | -4.55 | -5.5 | -11.97 | -15.94 | -37.67 | -31.14 | Upgrade
|
| Other Financing Activities | -2.45 | -3.23 | 2.14 | -2.56 | 2.05 | -3.57 | Upgrade
|
| Financing Cash Flow | -121.68 | -203.32 | -60.63 | -50.09 | -120.83 | -2.57 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.47 | 0.32 | 1.23 | 0.61 | 0.98 | -0.88 | Upgrade
|
| Net Cash Flow | -11.26 | -88.13 | 35.94 | -8.08 | -122.01 | 128.49 | Upgrade
|
| Free Cash Flow | 99.76 | 85.77 | 30.55 | 36.2 | -15.56 | 100.69 | Upgrade
|
| Free Cash Flow Growth | 207.55% | 180.72% | -15.60% | - | - | 19.22% | Upgrade
|
| Free Cash Flow Margin | 21.41% | 17.64% | 5.26% | 5.62% | -2.19% | 12.59% | Upgrade
|
| Free Cash Flow Per Share | 0.33 | 0.29 | 0.10 | 0.12 | -0.05 | 0.33 | Upgrade
|
| Cash Income Tax Paid | 24.22 | 23.76 | 26.21 | 22.48 | 30.03 | 47.81 | Upgrade
|
| Levered Free Cash Flow | 83.38 | 81.57 | 53.01 | 11.4 | -9.78 | 42.7 | Upgrade
|
| Unlevered Free Cash Flow | 86.59 | 84.78 | 59.94 | 21.76 | 2.53 | 58.61 | Upgrade
|
| Change in Working Capital | 37.26 | 37.26 | 13.4 | 54.48 | -13.94 | 63.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.